Abstract
The pressurised metered dose inhaler (pMDI) is one of the oldest and most commonly prescribed therapeutic systems for drug delivery to the lung. pMDIs are subject to rigorous 20 physical and chemical stability tests during formulation and prior to commercial approval.
Due to the time and cost associated with formulation and product development studies, there is a need, especially within an industrial setting, for novel techniques that allow fast screening 
Areas covered
This review highlights the state-of-the-art techniques and physico-chemical characterisation 30 tools that can potentially enhance the formulation and product development process for pMDIs. Techniques investigated include: laser diffraction, Raman spectroscopy, isothermal ampoule calorimetry, titration calorimetry and gas perfusion calorimetry. These are discussed in the context of pharmaceutical development, with a focus on their use for the determination of the physical and chemical stability in pMDI delivery systems. The operational principles 35 behind each technique are briefly discussed and complemented with examples from the literature. The strengths and weaknesses of the above techniques are highlighted with the purpose of guiding the reader to identify the most promising technique.
Expert opinion
Each technique has a unique set of advantages and disadvantages. Laser diffraction is 40 theoretically well placed to analyse real-time physical stability as a function of particle size, however its use is restricted to suspension MDI formulations. Raman spectroscopy requires little sample preparation and can be potentially used to attain both suspension and solution pMDI spectra in real time, however the majority of experiments are ex-valve chemical composition mapping. The next logical step in the development of Raman spectroscopy for 45 online pMDI monitoring is to begin in situ solid state analysis. Calorimetry is an effective technique in capturing both chemical and physical degradation of APIs in real time but requires redevelopment to withstand pressure for the purposes of pMDI screening. A combination of ampoule and gas perfusion calorimetry has the most potential to fast-screen for drug-propellant compatibility within a commercial environment. 50 
Introduction
The pressurised metered dose inhaler (pMDI) is one of the oldest and most commonly prescribed therapeutic systems for drug delivery to the lungs 1 . The popularity of this drug delivery system can be appreciated when observing its scale of growth in the global drug delivery market. The pMDI sector is expected to account for 59% of the global market, 85 worth $22 billion, for drug delivery systems by 2017 2 . The development of the first commercial pMDI began in 1955 by Riker Laboratories (now 3M Pharmaceuticals, St Paul, Minnesota) 3 and the original Medihaler design had key features (metering valve, canister, actuator orifice and mouthpiece) which are still present in modern devices 1 . Since the original introduction in 1955, pMDI formulations and inhaler designs have evolved to solve 90 technical problems, notably patients' uncoordinated inhalation technique 4 , high oropharangeal deposition, addition of dose counters 5 and the replacement of chlorofluorocarbon (CFC) with more 'ozone friendly' hydrofluoroalkane (HFA) propellants 6 .
95
The phasing out of CFC propellants in medical devices actively began in 1998 and was a slow, gradual process. The last two CFC inhalers, Combivent Inhalation Aerosol (Boehringer Ingelheim) and the Maxair Autohaler (Medicis Pharmaceutical Corporation) were taken off the US market in July 2013 and December 2013, respectively 7 . Advancements in pMDI technology have focused on the delivery of drug with greater efficiency (including dosing 100 reproducibility, delivering combination therapy and formulating proteins/peptides into pMDIs) and improving valve, elastomer and gasket design [8] [9] [10] . A list of Food and Drug Administration (FDA) approved products containing HFA, which are currently marketed in the US, is shown in Table 2 .
105
Drugs are formulated in either solution or suspension ( Table 2 ). Drugs that exhibit a small degree of solubility in HFA (i.e. have high enough solubility to be at risk from Ostwald ripening) are solubilised with co-solvents (usually ethanol) and formulated in solution. Drugs that are insoluble in HFA and ethanol co-solvent systems are prepared as a micron-sized suspension in HFA 11 . In order to reach the lung successfully, aerosols from pMDIs must 110 generate particles of an appropriate size for their target. For conducting airway deposition this is generally agreed to be between 3-6 µm and for small airways < 3 µm 11, 12 . The reproducibility of emitted dose and aerodynamic endpoints of the product are the primary outcomes for successful formulation and are critically dependent upon the physical stability of the active drug within the formulation. It is well known that suspension pMDI 115 formulations have the propensity to undergo either size-specific particle growth (Ostwald ripening), especially if the drug has a small degree of solubility in HFA, or agglomeration upon settling (flocculation and sediment compaction). These phenomena lead to variation in emitted dose and aerosol size distribution, which will be detrimental to aerosol performance. An excellent discussion on particle growth mechanisms in pulmonary dispersion formulations 120 is provided in a recent review article by O'Donnell et al 13 .
The chemical stability of drugs in HFA is a further drug-specific issue, which must be thoroughly screened. For example, the phenylalkylamino derivatives (eg. formoterol, salbutamol) are prone to degradation due to their susceptibility to oxidative conditions 14 . 125
Chemical instability is more likely to affect solution MDI products however 15 , as degradation rates in the solid state are generally orders of magnitude slower than in solution.
Furthermore, since water is likely to be present during the formulation process or during storage (via water ingression) 16 , hydrolytic degradation is a possibility 15 . Polymorphic screening of the active pharmaceutical ingredient must be performed as different 130 polymorphic forms have the potential to influence the performance and stability of the final product 17 .
Existing Basic Testing Requirements for pMDI stability
The chemical and physical properties of the drug determined prior to submission to the FDA 135 include density, particle size distribution, particle morphology, solvates and hydrates, polymorphs, amorphous form, solubility profiles, moisture and residual solvent content, microbial quality, dissociation constants and specific rotation of the drug. Assays to detect impurities or degradation products are commonly performed, with liquid or gas chromatography, and are either compared with products spiked with known impurities or 140 samples stored under relevant stress conditions (light, heat, humidity, acid/base hydrolysis and oxidation) 18 . Peak purity tests (diode array, mass spectroscopy) are typically included in the latter case as impurity or degradation standards are not available in this situation 18 .
For suspension formulations, tests to determine the particle size distribution and physical properties (shape, crystal habit, morphology, surface texture) of the active are also essential, 145 as these parameters are fundamental for drug product reproducibility and performance.
Assays for preservatives or stabilisers are also included in the submission documentation, as well as associated microbiological tests to determine if the formulation is susceptible to microbial contamination and colonisation.
Stability testing is a crucial step to identify likely degradation products under the influence of 150 common stresses (temperature, humidity and light) and so by extension to assess the intrinsic stability of the drug. A detailed stability protocol, based on ICH guidelines, is also required for a minimum of 6 months for intermediate and accelerated storage conditions, and 12 months at long term stability studies prior to the submission to the FDA. Ongoing re-tests intended for long-term ambient temperature and humidity studies are also conducted until the 155 point of product expiry, or re-testing at the 12 month mark for products which exhibit instability during accelerated and intermediate studies 18 . Stress testing is often repeated when manufacturing processes and analytical processes are refined 19 .
The analytical procedures to determine product acceptability for submission to the FDA and 160 ongoing stability studies include ultraviolet (UV) and infrared (IR) spectroscopy studies, high performance liquid chromatography/mass spectroscopy (HPLC/MS), tests for identification of the active drug, concentration assays and chirality assays to detect racemization if applicable 20 . The preferred method to detect degradation products is through reverse-phase HPLC (with a UV detector or coupled to MS), as it is compatible with aqueous and organic 165
solutions, highly precise and sensitive. Samples held under stress conditions are commonly screened with gradient method HPLC with varying mobile phase composition (usually low organic to high organic solvent) to assess the elution pattern of degradation products and/or related substances 21 .
170
Arguably, several limitations exist for conventional stability testing. Conventional techniques for determining drug degradation rates rely on product storage at elevated temperatures to accelerate the process. In conducting these trials, it is assumed that the degradation process follows the Arrhenius relationship 22 . This may not be true as drug could undergo a phase transition 23 , moisture redistribution or a change in reaction mechanism. Consequently there 175 may be two or more reactions occurring simultaneously 24 , or there may be alternative decomposition mechanisms that are activated only at high temperatures. For example, hydrate drugs or compounds that contain unbound water are prone to losing water at elevated temperatures and therefore will display different degradation mechanisms at these temperatures 25 . Extrapolation to determine rate constants would most likely result in error in 180 calculating stability at ambient conditions. Other limitations include the sampling frequency; if degradation plots have significant curvature or scatter, three or four data points may be insufficient to determine linear fit of data. Thus many time points are required.
In addition to the aforementioned limitations, current techniques are dependent upon the chosen sampling time within the ICH guidelines. The compatibility of the drug as a solution 185 or suspension in HFA is virtually unknown until the time of testing. Real-time analysis of degradation and incompatibility would quicken product development and increase data contribution to the Quality by Design (QbD) approach. There is an industrial need for novel techniques that are capable of online monitoring and that could screen the compatibility of new compounds/formulations with HFA propellant rapidly. This would prevent potentially 190 flawed products undergoing lengthy and costly stability studies. The subsequent sections of this review will discuss techniques used to detect solid-state stability, and stability of drug in both solution and suspension pMDIs.
2.
Rapid screening approaches for MDI stability 195
2.1
Laser diffraction
Laser Diffraction -ex valve measurement
Laser diffraction is a standard method in particle sizing and is used commonly in the pharmaceutical industry due to its short analytical time, reproducibility and high precision.
Briefly, laser diffraction measures particle size distributions by measuring the angular 200 scattering of light as it passes through a dispersed particulate sample. The changes in laser projection after the particle interaction are complex, and vary as a function of the scattering angle, particle size and shape and refractive index. The resultant diffraction pattern is converted into a volume-based size, derived using mathematical algorithms, normally the Lorenz-Mie theory of light scattering or the simplified Fraunhofer approximation 26, 27 . The 205 reader is directed to the ISO standard for further discussion on the operation principles of laser diffraction and information regarding the Mie theory and the Fraunhofer approximation 28 .
Several research groups have investigated the in situ geometric growth of crystalline drugs suspended in HFA propellant and the relation to aerosolisation and product stability post 210 actuation using laser diffraction systems. Smyth et al. investigated the effects of different ratios of EtOH:HFA-134a and the subsequent effects on geometric and aerodynamic particle size using both laser diffraction and an Anderson cascade impactor (ACI) 29 . The fine particle fractions (FPF) derived from both techniques were in striking agreement, although marked differences in the raw values for mass median diameter were shown. Similarly, a study by 215
Haynes et al. highlighted the need to develop further the existing Sympatec unit to achieve closer agreement with ACI data 27 . Berry et al. have previously established the link between increasing geometric particle size, measured as an aerosolised dry powder with a Sympatec HELOS compact laser diffraction system, with increased aerodynamic particle size distribution 30 . This study was conducted on different production batches of corticosteroid 220 material and only the influence of geometric particle size upon aerodynamic particle size diameter was assessed. Furthermore, sample pMDI formulations containing larger geometricsized particles were shown to be less stable under temperature cycling conditions, as particles shifted towards a larger aerodynamic particle size and decreased stage recovery.
These laser diffraction methods have usually been conducted 'ex valve'. However, to 225 investigate particle size and stability inside the canister extensive modification of the particle size instrument is required to allow pressurized measurement.
In situ Laser Diffraction -in situ measurement in propellant
Jones et al. also manufactured two types of pressure cells designed to be used with a 230
Mastersizer X laser diffraction instrument (Malvern Instruments, Inc., Southborough, MA) 31 .
The first type of pressure cell was a single sealed unit consisting of a plastic cell with two optical borosilicate glass surfaces through which powder was first placed inside the unit and HFA 134a propellant later filled through a specially adapted valve. The second unit was a pressurized cell manufactured by Malvern instruments, which incorporated a re-circulatory 235 system and filling apparatus. Two methods of recirculation were used in the measurement of the particle size distribution in HFA 134a suspension; continuous recirculation or stop flow circulation. The novel pressure cell sizing system showed a linear correlation with twinstage impactor results (r 2 = 0.8894; n=10) for particles < 6.4 µm for 8 novel HFA based pMDIs and 2 commercial HFA pMDIs. The degree of shear applied to the re-circulation 240 system was a source of potential measurement error; if the degree of shear supplied was insufficient there was a tendency to oversize the particles and likewise a process of overshearing resulted in the under sizing of particles. The authors obtained a strong correlation between laser diffraction and impaction results with method optimization.
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In summary the in situ laser diffraction method is well positioned to analyse the real-time physical stability of suspended micro particles in HFA as a function of particle size. Laser diffraction is reliable and capable of ongoing and online monitoring. Of significant importance is the ability to use "real propellants" to mirror the drug stability in a commercial product and its use can be expanded to study propellant combinations, titrations of surfactant 250 quantities or propellant-ethanol combinations. However laser light scattering also suffers from a number of disadvantages, limiting its more widespread use in stability studies. Exvalve laser diffraction measurements are prone to beam steering as a result of propellant vapour evaporation during the measurement. Beam steering may lead to changes in the refractive index of the gas phase within the spray, which result in the overestimation of the 255 particle size distribution. The laser diffraction method for in situ pMDI particle size measurements is restricted to suspension formulations, which accounts for just over half of all currently marketable products in the US (Table 2) . Whilst the technique is suited to detect fast-occuring physical processes that happen internally in the pMDI canister in the analysis time-frame, it is unsuited to detection of chemical processes, except in the situation of 260 particle size changes because of solvate formation. The mathematical calculation of the volume based size measurement also assumes all the particles are spherical, whereas in reality crystal growth will more commonly follow a needle-like or plate-like morphology and display high axial ratio (length to width ratio) growth 32 . The measurement of anisotropic particles or irregular-shaped particles can lead to inaccuracies in the particle size distribution 265 33 . Although the accuracy of laser diffraction measurement is absolutely necessary for the correlation of geometric data to aerodynamic particle size or for submission purposes to the FDA, the application of a fast-screening method only calls for the detection of significant deviation from time point zero, so as to signal whether to progress with the formulation. "It is important to note that any in situ laser diffraction measurement method must first be 270 optimized to ensure that particles are completely de-agglomerated to fully assess any changes in the primary particle size distribution that may occur as a result of Ostwald ripening.
However it is also important to note that excessive shear in a re-circulation laser diffraction system may prevent agglomeration that may have occurred as a result of formulation instability. Suitable method development which reflects the level of shear stress inflicted by 275 patient on the canister prior to actuation would be a pre-requisite prior to using this technique as an online monitoring tool. It is envisioned that further time-dependent ex-valve particle size distribution measurements or direct APSD measurements can be made once a formulation passes the initial in-situ stability screen."
The mechanism and application of Raman spectroscopy to MDIs Raman spectroscopy is an established technique for pharmaceutical and biopharmaceutical applications and can provide a characteristic "fingerprint" of intramolecular vibrations, which can be used to identify the molecular species, composition, the degree of order and disorder, structure and conformation 34 . Intermolecular interactions can also be identified through 285
Raman scattering. Raman spectroscopy is most sensitive to symmetrical covalent bonds, as strong Raman scattering occurs with a larger change in the polarisability of the distribution of the electron cloud. By extension, Raman spectroscopy can provide data on phases and phase transitions, hydrogen bonding, polymorphs, hydrates, anhydrates, molecular conformation, polymer chain confirmation 35, 36 and foreign particulate contamination 37 . "Raman may also 290 have utility in the measurement of amorphous content in formulations with high sensitivity.
Vehring et al has previously used dispersive Raman technique to identify mixtures of amorphous mannitol with a limit of quantification of 5% w/w 38 . The use of dispersive Raman spectroscopy in particular may be more sensitive than FT-Raman, as Raman scattering cross sections and charge coupled device detector sensitivity increase with lower 295 excitation wavelengths.
Raman spectroscopy is also ideal for aqueous systems as highly polar bonds (eg. O -H bonds) have a weak vibration and low Raman scattering due to their low polarisabilityRaman is less susceptible to convolution by water compared with IR methods. Further discussion of the theoretical aspects of Raman scattering is provided by Ozaki et al. 39 and an excellent 300 overview of the different types of Raman spectroscopy with respect to drug delivery systems is given by Mansour et al. 35 .
Raman scattering has been used to measure size, composition and temperature gradients of drying droplets 34, [40] [41] [42] such as the evaporation of water from mixed water/glycerol droplets 305 43 , ethanol/water droplets 41, 44, 45 , methanol/water droplets 41 , 1-propanol/water droplets 41 , coagulation of droplets 46 , phase transitions of inorganic salts particles 47, 48 and chemical reactions between binary droplets 45, 47 . Raman spectroscopy can be used to elucidate intermolecular interactions in the condensed phase, such as the hydrogen bonding that occurs in liquid water 49, 50 . 310
Quinn et al. were the first to use Fourier Transform Raman (FT -Raman) spectroscopy as an analytical tool to assess lysozyme protein conformation in suspension formulations in the HFA propellants tetrafluoroethane (HFA-134a) and heptafluoropropane (HFA-227) 51 .
Additionally, this study was the first to capture the background Raman spectra of both HFA-315 134a and HFA-227 with excellent signal-to-noise ratio. Descriptions of vibrational modes (e.g. stretch, deformation) were assigned to particular wavenumber bands. The structural integrity of lysozyme in HFA-134a and HFA-227 was elucidated by subtracting the spectra of the blank propellants from the Raman spectra of the HFA -lysozyme suspensions. FTRaman spectroscopy provided structural information of the lysozyme backbone, disulfide 320 bonds and C-C stretching vibrations.
Hot-stage Raman spectroscopy has been used by Bouhroum et 57 . This detection method is beneficial and time saving, since the standard array methods are based on incubation on agar plates, impaction and filtration. 345
Theoretically, the use of Raman spectroscopy for the online monitoring of drug stability in inhalers confers a number of advantages. The Raman analysis sampling time is short and therefore would expedite formulation development and the QbD approach. Spectra can be obtained non-invasively with little sample preparation, thus avoiding costs and errors due to 350 preparation (eg. evaporation of propellant and grinding of drug sample which could lead to changes in solid state). The major disadvantage of Raman scattering is that it is a weak effect, as the incident photon is not absorbed and therefore is much smaller than the molecular disturbance for fluorescence or infrared 58 . Shifting the laser wavelength to the near infrared spectral region (800 -2500 nm or 12500 to 4000 cm -1 wavenumber) can avoid the 355 fluorescence overlap in most cases. The measurement container must also be transparent to visible or near-infrared laser light to minimize spectra interference.
Isothermal calorimetry
Calorimetry operates on the principle of detecting heat (a universal accompaniment to 360 chemical and physical change). A material may change its physical form or chemical structure through the interaction with another species or as a result of environmental conditions. The measurement of this change is crucial to determining the time frame in which the transformation would occur. Measurement of the heat output from a process (q, SI units Joules) will give thermodynamic information, while the measurement of heat output with 365 time (dq/dt) conveys kinetic information. Thermodynamics, which is the study and quantification of transformations of energy, is a core principle on which calorimetry is based.
Thermodynamics is concerned with heat (q) and its relation to the two process-dependent terms: energy (U) and work (w), and macroscopic variables of volume, pressure and temperature associated with those systems. Further explanation of thermodynamics in 370 relation to calorimetry is given by Gaisford and O'Neill 59, 60 .
As heat is a universal accompaniment to chemical and physical change, calorimetry is well placed to study non-destructively long-term chemical and physical events such chemical degradation, ageing, recrystallisation or the formation of hydrates/solvates. The technique 375 itself is sufficiently sensitive to allow detection of degradation directly under storage conditions, which is a major advantage when checking product viability. The sensitivity of isothermal calorimetry has been proven to be a useful method to confirm solid-state degredation rates. Its precision exceeds standard methods such as determination of degredation through time course chemical degredation studies followed by HPLC to 380 determine activation energies 23, 25 and overcome limitations such as the need for a suitable chromophore and the requirement to measure in solution form 59 . Three types of isothermal calorimetry instrumentation are discussed in the sections below: ampoule calorimetry, titration calorimetry and gas perfusion calorimetry. 385
Ampoule calorimetry
Ampoule calorimetry is the most common type of isothermal experiment. The setup involves sealing the material or test subject in an ampoule, typically constructed from glass or metal.
Ampoules typically contain up to 20 mL of sample 61 By plotting ln k against the reciprocal of temperature it is possible to extrapolate back to ambient temperature and determine the rate constant at that temperature. The findings by 420
Koenigbauer demonstrated that isothermal calorimetry was proven to be more precise than conventional HPLC and could determine slow degradation rates that could not be determined with HPLC (e.g. phenytoin, triamterene, diltiazem, theophylline) 25 Dl-α-tocopherol, a viscous liquid, was exposed to varying intervals of oxygen before sealing and measuring with the calorimeter. An Arrhenius plot was derived from a combination of both HPLC and isothermal calorimetry methods, with HPLC used to determine degradation 435 rates from temperatures 80 -50°C and isothermal calorimetry 40 -23 °C. No marked discrepancy was observed in the linear regression drawn between the two methods. The study further concluded that the HPLC method would require a period of one year or more to determine the dl-α-tocopherol rate constant at lower temperatures (23 °C) and thus isothermal calorimetry was suggested to be highly advantageous in this circumstance. Tan et al. used 440 microcalorimetry to investigate the solid state stability of 13-cis-retinoic acid and 13-transretinoic acid in the presence and absence of oxygen 63 . Rates of degradation of both compounds were determined through microcalorimetry and confirmed with HPLC. Both half-life and shelf lives at room temperature could be extrapolated from rates of degradation.
Samples in the absence of oxygen displayed first order reaction kinetics from 445 microcalorimetry, but HPLC analysis showed no degradation, which suggests that microcalorimetry was able to detect a physical change.
Similarly, an ampoule isothermal calorimetry study was conducted by Pikal et al. on cephalosporins in the solid state form which concluded that the technique was capable of 450 detecting decomposition rates as low as 1% per year with an overnight experiment 23 . All of the studied amorphous compounds and the crystalline non-stoichiometric hydrate of ceftazidime showed decreased stability at higher water content, which was expected as water is a likely reactant in the decomposition of cephalosporins. Pikal also theorized that the annealing process, which is the decrease in energy of an amorphous solid as a function of 455 storage time, contributes to the thermal activity of amorphous solids but its contribution decreases as a sample approaches equilibrium. The method presented is currently the most direct method to study thermal interactions arising from drug-propellant interactions. However the equilibration period (up to 30 min) limits the method from fully capturing crystallization events, especially those that occur rapidly. The addition of amorphous drug to a cooled HFA environment may also lower the 470 rate of crystallization, and therefore artificially lower the heat output (q) ( Equation 6) 65 .
Titration calorimetry
In isothermal titration calorimetry (ITC), small volumes of titrant solution are added sequentially to a solution of substrate held within the calorimetric vessel ( Figure 1 ). The 475 number of titrations is calculated to ensure the reaction progresses past its end point.
Integration of the data allows construction of a binding isotherm, from which the binding constant can be determined. Several control experiments are needed to take into account dilution of the substrate and dilution of the ligand. An example of ITC used to study pMDI formulations is provided in Figure 2 ; the surfactant polyethylene glycol was titrated into a 480 suspension containing spray dried salbutamol sulphate in decafluoropentane to ascertain the ideal ratio of surfactant coverage to surface area of drug.
As heat is ubiquitous, isothermal calorimetric data are limited in specificity, but conversely the technique is ideally suited to study complex, heterogeneous samples. Isothermal titration 485 calorimetry has been extensively employed to academically study the self-assembly of micellar systems [66] [67] [68] [69] , drug -surfactant interactions [70] [71] [72] , polymer -surfactant interactions 73, 74 , ligand binding [75] [76] [77] , enzyme activity 78, 79 , protein -protein reactions 80, 81 , lipid -lipid systems 82 and lipid -small molecule interactions 83 . A broader summary of isothermal titration calorimetry applications from 2010 can be found in Ghai et al. 84 . Multiple studies 490 have utilised isothermal titration calorimetry to investigate the energetics of surfactant-based systems 71, 85, 86 . The majority of these studies have been conducted in an aqueous medium;
however there is one key study that is of relevance to pMDI systems. Blackett et al.
investigated the absorption of oleic acid and Span 85 onto amorphous and crystalline salbutamol sulphate in an attempt to assess the effect of surface energy properties on 495 surfactant -drug interactions in Arcton-113, a model propellant (1,1,2-tri-chloro-tri-fluoroethane) 86 . Three batches of salbutamol sulphate were used; freshly milled, milled and stored at 78% relative humidity (RH) for 72 hours to encourage re-crystallisation, or stored at 78%
RH for 72 hours and returned to 0% RH for at least 24 hours to reproduce an "aged dry sample". Samples (50 mg) of each batch of salbutamol sulphate were suspended in Arcton-500 113. It was established that the freshly milled sample was partially amorphous, whilst the crystalline samples were shown to be > 99.7% crystalline (the detection limit for crystalline materials using ampoule isothermal calorimetry). Two solutions, oleic acid and Span 85 in Arcton-113, were titrated separately into the calorimeter ampoule containing the suspension of drug in the non-polar model propellant. Calorimetric data revealed that adsorption of both 505 surfactants onto partially amorphous surfaces produced a net endotherm as surfactant concentration increased, which was a result of a combination of exothermic (surfactant adsorption) and endothermic (particle deaggregation) events. Crystalline samples did not disperse when surfactant was added, which therefore resulted in a net exothermic event with respect to surfactant concentration. Titration calorimetry was a suitable technique to probe 510 liquid-surfactant-drug interactions in the model pMDI system in real time.
Despite the promise for the detection of key events associated with pMDI stability, ITC suffers from a lack of ability to use commercial propellants, which are only liquid under elevated pressure, and requires redevelopment to withstand pressures up to and beyond 6.7
Bar. 515
Gas perfusion calorimetry
Gas perfusion calorimetry involves the controlled flow of vapour over a solid sample in the measuring ampoule of the calorimeter. The vapour is commonly an organic solvent or humidified air and is specifically chosen to interact with the sample in some way. The vapour 520 is transported using a carrier gas, usually nitrogen, which passes through two solvent reservoirs prior to the measuring ampoule. A second gas line is used to carry a dry gas, also usually nitrogen. Mass flow controllers are used to regulate gas flow along the two line; defined partial pressures of vapour can be created by proportional control of the flow rates.
Partial pressure can be altered either in steps or a linear ramp. Typical examples of gas 525 perfusion calorimetry include the use of vapour to probe specific binding sites on the sample surface, wetting the sample to induce the formation of hydrates or solvates and inducing recrystallisation of an amorphous material 60 .
Originally, the determination of amorphous content in powders was conducted by introducing 530 a glass hydrostat containing either a reservoir of pure water or salt solution into an ampoule calorimeter 87 . The first published study, conducted by Briggner et al., utilised isothermal calorimetry to investigate the crystallisation of spray-dried and micronised lactose monohydrate 87 . It was found that the amount of amorphous material produced by micronisation was directly proportional to the microcalorimetric observations correlated to 535 the recrystallisation of lactose in response to humidity exposure. It was proved that the detection limit of the percentage of amorphous material was 1% or less, which far exceeded the 5-10% limit of detection for differential scanning calorimetry (DSC) and X-ray Powder Diffraction (XPRD) 22 . Ahmed et al. investigated the use of gas isothermal calorimetry using organic vapours to characterize the amorphous content of drugs with poor aqueous 540 tolerability. The study agreed with previous literature, and identified a detection limit of 1% amorphicity 88 . With the advent of the gas perfusion device, the exact RH or relative vapour pressure experienced by the sample can be controlled by adjusting the flow rates of the purge gas through the dual lines 59 .
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The isothermal gas perfusion apparatus has been used in a recent study by Ooi et al. to investigate the interaction of model propellant 2H,3H-decafluoropentane with beclomethasone dipropionate and salbutamol sulphate 89 . The early stages of beclomethasone dipropionate-decafluoropentane clathrate formation were successfully captured. The stability of salbutamol sulphate in HFA-227 was also predicted using microcalorimetry coupled with 550 multiple analytical methods. The disadvantage of this technique is the inability to currently utilize pressurized liquids at STP. The substitution of HFA with the higher molecular weight HPFP model propellant gives an indication of API stability in HFA but a shift towards utilizing true HFA propellants is necessary for the further development of this technique.
The replacement of the internal perfusion shaft O-rings and the redesign of the mass flow 555 controllers are factors to consider when developing gas perfusion calorimetry to withstand fluorinated propellants.Broadening the selection of powders to include commercially manufactured active pharmaceutical ingredients for gas perfusion testing is necessary to compare this method with traditional long-term studies.
Conclusions
This review has examined the use of analytical techniques, such as Raman spectroscopy, Calorimetry is effective as it is able to detect both chemical and physical degradation of an API as a function of heat; however it is unfortunately unable to distinguish between the two processes. Whilst this is not absolutely necessary if calorimetry is to be used as a fast-screen 595 method for API-propellant compatibility, additional tests will be required to determine the reason for drug instability. Ampoule calorimetry, whilst it can be adapted to be filled with pressurized HFA, is unable to detect rapidly occurring degradation events, as an initial calibration and temperature stabilization of the sample ampoule is required prior to measurement. It is thus challenging to determine accurately the overall rate of degradation. 600
Loss of the initial data does not occur when gas perfusion calorimetry or titration calorimetry are used. Both gas perfusion and titration calorimetry are currently well placed to measure solid-gas or solid-liquid interactions and have been used with model HFA propellants, but require re-development to withstand pressures of up to and beyond 6.7 Bar to mirror pressures in a typical liquid HFA-134a environment. The correlation of enthalpy to particular 605 formulation parameters, namely the EtOH-HFA ratio, drug-surfactant ratio, drug degradation rates, canister pressure and excipient compatibility are areas that could be assessed with this dual system and quicken formulation development. The possibility of studying elastomer swelling or valve degradation in pressurized hydrofluoroalkane is another possibility and can be achieved by substituting the powdered sample for the elastomer or valve material in the 610 TAM ampoule. Future TAM studies will need to utilize high percentage crystallinity particles with clean, predictable surface characteristics to mirror more closely an industrial micronized drug product. The "whole system approach" of ampoule calorimetry combined with the investigations of the initial propellant-drug reaction with gas perfusion calorimetry is best placed to fast-screen for drug-propellant compatibility and has the most extensive 615 application set for pMDI testing within a commercial lab. The study of the phase transformations of organic compounds under pressure is another area of development that is complementary to thermal analysis. Further developments on the kinetics of propellant mediated phase transformation of organic compounds with synchrotron SAXS/WAXS radiation will be beneficial in identifying intermediate organic phases and contributing to the 620 a high throughput for formulation development.
Expert Opinion
Understanding the factors that affect API stability in hydrofluoroalkanes has been the focus 625 of much empirical research within the last 20 years, since the switch from the chlorofluorocarbons to hydrofluoroalkane propellant vehicle. Previous pMDI research has focused on separate failure modes for pMDIs, including solubilisation properties of the hydrofluoroalkanes and propellants, the interaction of propellant and active pharmaceutical ingredients, the chemical interaction between multiple pharmaceutical ingredients in a 630 propellant environment, the interaction of ingredients with device components and the effects of water and leachables.
The achievement of a functional online monitoring tool seeks to detect formulation defects, which may involve more than one mode of failure. The detection of issues with formulation quality prior to stability testing will benefit the pharmaceutical industry immensely, in terms 635 of improving manufacturing efficiency, reducing waste and shortening the development time for new products. There are also immediate, practical and financial benefits associated with pulling products which are deemed unsuccessful prior to undergoing lengthy stability studies.
Substantial progress has been made towards developing online monitoring tools for pMDI production; the key chemical and physical properties of propellants have been documented 640 along with compatibility studies involving elastomers and plastics and solubility studies with APIs. Background infra-red and raman spectra of propellants have been documented by academic groups. In situ experiments involving characterisation of APIs in a pressurised propellant environment have been developed using laser diffraction, isothermal calorimetry, and Raman spectroscopy. Key findings in the literature indicate that there is practical 645 application of the aforementioned methods to stability testing as these methods are relatively fast, easy to operate, require little sample preparation and are capable of being integrated into pMDI formulation development or batch testing.
However, several challenges are apparent in above approaches for stability testing. Firstly, they are not designed to detect pMDI failures associated with the device, which includes 650 batch to batch variations on pMDI seals and gaskets, slight leakages, leachables from both sealing and canister materials, canister material properties and coatings or actuator malfunctions. The possibility of studying elastomer swelling or valve degradation in pressurized HFAs can be achieved by substituting the powdered sample for the elastomer or valve material in the calorimetric ampoule. It is also possible to mimic the canister surface in 655 calorimetric experiments by coating the internal surfaces of sample and reference ampoules with polymeric materials. If the latter is chosen, recalibration of the instruments will be required to take the different heat conduction properties into account. Calorimetric methods may be the most sensitive method to determine both chemical and physical stability, however further developmental work must be performed to define the enthalpy limits for in situ 660 crystallisation, agglomeration and/or dissolution. Another disadvantage for the screening methods is that the reason for pMDI failure may not be readily apparent. The inclusion of ethanol in metered dose inhaler formulation is another dimension which must be considered; solubilisation of the API via ethanol will transform the suspension into a solution, thus causing in situ laser diffraction measurements to be ineffective. 665
Future work in this field of study must be directed to determine the limit of detection for the above methods, and attempt to establish a relationship between the residual aerodynamic particle size distribution and the rate of in situ API crystallisation, sedimentation or agglomeration. Despite the technical challenges encountered for predicting formulation stability in pMDIs, pre-emptive screening approaches are highly sought after due to the 670 immediate benefits for manufacturing efficiency, waste reduction strategies and pMDI formulation. Table 2 . FDA approved products containing HFA which are currently marketed in the US 
